Description

1,3-Dimyristoyl-2-Eicosapentaenoyl Glycerol is a structured triglyceride (TAG) where the sn-1 and sn-3 positions are esterified with myristic acid (C14:0) and the central sn-2 position is occupied by the ω-3 fatty acid eicosapentaenoic acid (EPA, C20:5). This specific molecular architecture is engineered to enhance the bioavailability and targeted delivery of EPA, a compound of significant nutritional and pharmaceutical interest. It is a critical intermediate and active ingredient for advanced research and product development in the nutraceutical and pharmaceutical sectors, particularly for formulations requiring precise lipid structuring.

Application

• Pharmaceutical Drug Delivery: As a key lipid excipient in advanced drug delivery systems, including self-emulsifying drug delivery systems (SEDDS) and lipid nanoparticles, to improve the solubility and absorption of poorly water-soluble active pharmaceutical ingredients (APIs).
• High-Purity Nutraceuticals: Serving as a concentrated, structured source of EPA for premium dietary supplements, functional foods, and medical nutrition products aimed at supporting cardiovascular, cognitive, and anti-inflammatory health.
• Biomedical & Clinical Research: Used as a standard or experimental compound in lipidomics research, metabolic studies, and clinical trials investigating the effects of structured triglycerides on lipid metabolism and health outcomes.
• Cosmetic Actives: Incorporated into high-end skincare formulations for its potential skin-barrier reinforcing and anti-inflammatory properties.
• Chemical Synthesis Intermediate: Employed as a specialized building block for the synthetic preparation of more complex lipids, phospholipids, and prodrugs.

Basic Information

Product Name	1,3-Dimyristoyl-2-Eicosapentaenoyl Glycerol
CAS No.	191786-55-7
Molecular Formula	C49H84O6
Molecular Weight	769.2 g/mol
Synonyms	1,3-Ditetradecanoyl-2-(5Z,8Z,11Z,14Z,17Z-eicosapentaenoyl)-glycerol; EPA-MAG-Myr; Glyceryl 1,3-dimyristate 2-eicosapentaenoate; TAG (14:0/20:5/14:0); Structured Triglyceride EPA/Myristic Acid; 1,3-Di(tetradecanoyl)-2-[(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoyl]glycerol; sn-1,3-Dimyristoyl-sn-2-eicosapentaenoyl Glycerol
EINECS	Contact for details

Quality Control

Our 1,3-Dimyristoyl-2-Eicosapentaenoyl Glycerol is manufactured under strict quality management systems. Each batch is subjected to rigorous analytical testing, including chromatographic purity assays and identity confirmation, to ensure it meets high-purity standards suitable for research and formulation. Certificates of Analysis (COA) detailing specific batch results are available upon request.

Storage

Preserve in a tightly closed container, protected from light. For long-term stability, store at -20°C or below under an inert atmosphere (e.g., nitrogen or argon) to prevent oxidation. Allow the sealed container to reach room temperature before opening to minimize moisture condensation.

Specification

Item	Specification
Appearance	Colorless to pale yellow oily liquid
Identification (IR)	Conforms to structure
Assay (HPLC)	≥ 95.0%
EPA Content (sn-2 position)	≥ 90.0% of total sn-2 fatty acids
Myristic Acid Content (sn-1,3)	≥ 90.0% of total sn-1,3 fatty acids
Peroxide Value	< 5.0 meq/kg
Acid Value	< 2.0 mg KOH/g
Water Content (KF)	< 0.5%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.